AlphaMadera's AlphaVal page computes Mettler-Toledo International Inc.'s fair value using a multi-method blend (DCF, comparable-multiples, and Graham-style intrinsic value), then compares it to the current market price to flag MTD as undervalued, fairly valued, or overvalued.

What is Mettler-Toledo International Inc.'s fair value?

Fair value for MTD is a model output combining discounted cash flow projections, peer-group multiples, and a Graham number floor. The live AlphaVal page shows the blended fair value alongside each method's individual estimate.

How does AlphaMadera value MTD?

AlphaVal uses three primary techniques: a five-year discounted-cash-flow projection with terminal multiple, peer-group multiple analysis (P/E, EV/EBITDA, P/S), and Graham's defensive-investor intrinsic-value formula. Inputs come from MTD's most recent reported fundamentals.

MTD - Mettler-Toledo International Inc.

Price: -- -- | CONSENSUS: Hold DETAILS | PRICE TARGET: $1,442.00 DETAILS

AlphaVal

Deterministic, archetype-aware fair value

Stable Earnings Power 80% confidence

Primary model: P/Adj-EPS × Normalized Multiple

Valuation Signal Overvalued Moderate

Trading 30.1% above fair value

Current Price $1103.09

Bear Case $678.22 38.5% downside ($678.22 - $1,103.09) / $1,103.09 = -38.5% $43.31 × 12x P/E

Fair Value $847.78 23.1% downside ($847.78 - $1,103.09) / $1,103.09 = -23.1% $43.31 × 15x P/E

Bull Case $1,017.34 7.8% downside ($1,017.34 - $1,103.09) / $1,103.09 = -7.8% $43.31 × 18x P/E

Adjust Assumptions

P/E Multiple

15.0x

Adjusted EPS

43.31$

Key Value Driver

Normalized P/E multiple (15x base case)

Implied Market Multiple 25.5x

Plain-Language Summary

Our base-case estimate uses a valuation based on adjusted earnings per share and a normalized price-to-earnings multiple. We then blend that result with the average analyst price target of $1442.00 from 19 analysts, using a 25% weight on analyst consensus. That produces an estimated intrinsic value of $847.78 per share.

Warnings

ℹ Wall Street's average price target is $1442.00 (from 19 analysts). Our estimate is 55% below the consensus -- consider that gap carefully.

Key Risks

Growth DCF inappropriate — terminal value assumptions dominate
EV/EBITDA misleading for regulated businesses where capex is mandated
Regulatory risk is a fat tail not visible in normal multiples